Cisco anuncia un ‘router’ ultrapotente para conectarse a Internet

NUEVA YORK (AFP) – El fabricante estadounidense de equipos de telecomunicaciones Cisco anunció que ha diseñado un ‘router’ 12 veces más potente que el de sus adversarios, el cual permite conexiones a Internet tan rápidas que, por ejemplo, será posible descargar en un segundo todos los textos de la biblioteca del Congreso de EEUU.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment.

With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies.

BERLÍN (AFP) – Un árbitro de la federación alemana de fútbol (DFB) figura entre los sospechosos en la investigación de una trama de partidos trucados desmantelada el jueves en varios países de Europa, según el semanario Der Spiegel que se publicará el próximo lunes.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at.

About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro.

Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks  |  Media  |  China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported.

PARIS (AFP) – Eric Rohmer, fallecido este lunes en París a la edad de 89 años, era el más secreto de los cineastas de la llamada ‘Nueva Ola’ (‘Nouvelle Vague’) del cine francés, autor de comedias frescas y sentimentales pobladas de muchachas en flor.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.

Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements.

Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext.

406, . FREDERICK, MD, Jun 19 (MARKET WIRE) — BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive,disposable drug-free anti-inflammatory devices, today provided itsinvestors with a summary of the conference call held after the marketclosed on Thursday, June 18th. On the conference call, the managementteam discussed the numerous ongoing clinical trials, expected FDAsubmissions and the Company’s marketing plans through the end of theyear. Because attendance in the call was significantly more than expectedwith more than 575 investors attempting to access to the call, whichoverwhelm the conference calling system, the Company is providing thefollowing summary for those investors who were unable to participate.The major emphasis of the call was the numerous clinical trials currentlyunderway, several of which are completing the final stages. These clinicaltrials will be used as the basis for additional applications to the FDAfor 510(k) marketing clearance.”We want to thank everyone for their overwhelming level of enthusiasmrelative to our recent corporate progress. Our near-term objective is toreceive FDA clearance to market our products over the counter in thedrugstore and grocery store chains within the United States, commentedAndrew Whelan, CEO of BioElectronics Corp.

LA PAZ (AFP) – El director español Mateo Gil llevará al cine las andanzas en Bolivia a principios del siglo XX del célebre bandolero estadounidense Butch Cassidy, que será interpretado por el actor Sam Shepard, en una mezcla de hechos reales e interpretación histórica, indicó el jueves a la AFP el coproductor de la cinta Paolo Agazzi.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research.

“The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology.

In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies. Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster. In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles.

Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys. What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation. For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Barr Pharmaceuticals Generics CompanyIntelligence Report” company profile to their offering. Barr Pharmaceuticals is one of the USA’s leading generic manufacturers.

MÉXICO (AFP) – México intensificó las acciones contra el cártel de los hermanos Beltrán Leyva, tras la muerte en diciembre de su líder, Arturo Beltrán, en un operativo militar y la reciente captura de otro hermano, un linaje que apenas representa una pieza en la poderosa estructura del narcotráfico mexicano.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction.

The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements.

Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements.

The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. 406, . FREDERICK, MD, Jun 19 (MARKET WIRE) — BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive,disposable drug-free anti-inflammatory devices, today provided itsinvestors with a summary of the conference call held after the marketclosed on Thursday, June 18th. On the conference call, the managementteam discussed the numerous ongoing clinical trials, expected FDAsubmissions and the Company’s marketing plans through the end of theyear.

HONOLULU, EEUU (AFP) – Olas de tsunami provocadas por un sismo de 8,8 grados de magnitud ocurrido este sábado en Chile, que dejó al menos 147 muertos, se desplazan a lo largo del Océano Pacífico y se dirigen hacia Japón, afirmó un responsable de la agencia meteorológica estadounidense.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment.

With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies. Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster.

In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys. What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation. For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009.

Envoys for the leftist Zelaya, who was toppled and forcedinto exile by soldiers on June 28 but is now back in thecountry, and for de facto leader Roberto Micheletti tackled forthe first time the issue of Zelaya’s future. Those practices prevented consumers from comparing pricesand the quality of products and curtailed the effectiveness ofthe clubs as competitors, the FTC charged. “ATMC is an excellent example of how a carrier can secure new business utilizingCES,” stated Steven Curtis, senior vice president of sale and service at TelcoSystems. “They want the natural resources and they want to take itoutside Period,” he said. All other trademarks mentioned hereinare the property of their respective owners.Contact:Jason A. Smartphones are morphing into devices on which users can surf the Internet and read Word documents, and the XPPhone could be pushing the ante with support for Windows XP. Kampa, “When the Form10K is filed in the next few days, our attorneys advise us that the “E” shouldpromptly be removed from the Company`s trading symbol.

Ian Lesser, from the German Marshall Fund of the UnitedStates, said that by inviting Ahmadinejad and Bashir, Turkeymight deepen perceptions its foreign policy is ambiguous. Additionally, customers are invited to the Ponce store`s grand openingcelebration, and to take advantage of a number of activities and promotions,including: discount coupons, product giveaways and vendor demonstrations. For moreinformation visit The Stevie AwardsStevie Awards are conferred in four programs: The American Business Awards,The International Business Awards, The Stevie Awards for Women in Business,and The Stevie Awards for Sales & Customer Service.Honoring organizations ofall types and sizes and the people behind them, the Stevies recognizeoutstanding performances in the workplace worldwide.Learn more about TheStevie Awards at of the 6th annual Stevie Awards for Women in Business (as of October9) include the Business TalkRadio Network, Covario, Inc., and KeyBank. In my tests, the popular section had trouble switching between topical tweets.

SportsAuthority operates 465 stores in 45 states, and employs more than 15,000associates nationwide. Upon submitting the form via fax or e-mail,each applicant will be contacted and provided with details regarding credentialspick-up, schedule of activities, interview opportunities, and other importantinformation No accreditation requests will be accepted by phone. DOE will provide further details of the grant conditions in thenear future. LOS ANGELES (Hollywood Reporter) – Moon Bloodgood, Jessy Schram, Seychelle Gabriel and Maxim Knight have joined Noah Wyle on TNT’s untitled alien invasion pilot from executive producer Steven Spielberg. – Six wells have been drilled for early production onCepu’s main Banyu Urip field, which is estimated to havereserves of 350 million barrels, including two to re-inject gasand water. The decreasein MME gross profit was primarily due to the decreased MME net sales discussedabove and a decrease in vendor consideration in Q2 2009.

MADRID (AFP) – El Ibex-35, índice de los principales valores de la Bolsa de Madrid, ganó este jueves 53,50 puntos (un 0,46%) y se situó en 11.594,70 tras la caída de la víspera (de un 2,27%), provocada por la decisión de Standard & Poor’s de calificar de “negativa” la perspectiva de la economía española.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at.

LONDRES (AFP) – El ministro de Exteriores británico, David Miliband, aseguró este martes que no había ninguna “confrontación” con Teherán y calificó de “puramente consular” la detención por la Marina iraní de cinco navegantes británicos en aguas del Golfo la semana pasada.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system.

The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.

LUANDA (AFP) – Egipto, única selección entre los semifinalistas del torneo que no participará en el Mundial de Sudáfrica, obtuvo su tercera Copa de África de Naciones (CAN) de fútbol consecutiva, este domingo en Luanda al derrotar en la final por 1-0 a la selección de Ghana.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds.

The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc.

is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements.

Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext.

HOI AN, Vietnam (AFP) – - El tifón Ketsana provocó la muerte de al menos 55 personas en Vietnam y de otras 11 en Camboya, después de haber pasado por Filipinas, uno de los paises más afectados, donde dejó 246 víctimas fatales.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.

This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine.

The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide.

Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks  |  Media  |  China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine.

TOKIO (AFP) – Japón se mantuvo como segunda economía mundial en 2009 por escaso margen, con un producto interior bruto (PIB) nominal de 5,075 billones de dólares, contra 4,9 billones de China, según estadísticas publicadas este lunes por el Gobierno japonés.

The FDA staff memo was released ahead of an advisory panelmeeting, scheduled for Tuesday, where outside experts willreview the safety of various drugs for children. Depakote was once a blockbuster for Abbott but salesdropped sharply after generic competitors became available.First-quarter sales for the drug were $110 million. “For many women, Depakote may be the only effectivemedicine to control their seizures” and doctors and patientsshould evaluate the drug’s risks versus its benefits, Powerssaid. At the same time webelieve that SanJiang will facilitate our ability to get all relatedlogistics in place and to obtain further land assets as needed.”ABOUT SANJIANG AGRICULTURE CO LTD.SanJiang Agriculture Co Ltd. We will provide thetechnology, know-how and management of the operation. Under the Joint Venture,SanJiang will provide the land and factory buildings. Credit Agricole was also told by the antitrust not to take arole in corporate governance at Intesa Sanpaolo but under itsoriginal pact with Generali it did.

The two suspended their original agreement until June 30 andare putting together a revised pact which they hope will satisfyantitrust authorities. TOUGH MEASURES? The source said on Friday that if the antitrust authorityreceived a formal request for an extension of the deadline tosell, it was likely to accept but impose restrictions on thestake. The authority granted an extension to Italy’s biggest bank,UniCredit (CRDI.MI) on selling 3.24 percent of Generali lastyear with the condition of suspending voting rights. Intesa Sanpaolo could face a fine of up to 5 billion eurosfrom the antitrust, newspapers have reported, for failing toensure shareholders meet its requirements. On Friday, Intesa Sanpaolo’s chief executive, CorradoPassera, said its shareholders would find a solution if the bankfaced a fine. “Shareholders will find a solution which won’t createproblems for the bank,” Passera said on the sidelines of aconference in Milan He gave no further details. One analyst suggested Intesa Sanpaolo might try to share thepossible fine with Credit Agricole and Generali.

ROMA (AFP) – - El ciclista Francesco De Bonis, quien ya había sido suspendido por manipulación de productos sanguíneos, fue controlado positivo por eritropoyetina (EPO) tipo Cera en la primera etapa del Giro de Italia, el 7 de mayo pasado, informó este miércoles la prensa italiana.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.

KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine.

The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots.

PEKÍN (AFP) – China se opone a las presiones de los otros países en favor de una reevaluación del yuan y no cederá, declaró este domingo el primer ministro Wen Jiabao en la clausura de la sesión anual del Parlamento.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment.

With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology.

BRUSELAS (AFP) – Los líderes de la Unión Europea, reunidos el jueves en cumbre en Bruselas, aceptaron la derogación exigida por el presidente checo, Vaclav Klaus, para firmar el Tratado de Lisboa, levantando uno de los últimos obstáculos para su ratificación, indicaron fuentes oficiales.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators.

CARACAS (AFP) – Las autoridades venezolanas confirmaron este viernes el fallecimiento de los nueve tripulantes de un buque de bandera griega siniestrado frente a la costa venezolana, que habían sido reportados previamente como desaparecidos.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement.

Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S.

Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements.

We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. 406, . FREDERICK, MD, Jun 19 (MARKET WIRE) — BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive,disposable drug-free anti-inflammatory devices, today provided itsinvestors with a summary of the conference call held after the marketclosed on Thursday, June 18th. On the conference call, the managementteam discussed the numerous ongoing clinical trials, expected FDAsubmissions and the Company’s marketing plans through the end of theyear. Because attendance in the call was significantly more than expectedwith more than 575 investors attempting to access to the call, whichoverwhelm the conference calling system, the Company is providing thefollowing summary for those investors who were unable to participate.The major emphasis of the call was the numerous clinical trials currentlyunderway, several of which are completing the final stages.